Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes
Language English Country United States Media print
Document type Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
15721120
DOI
10.1016/j.amjcard.2004.10.050
PII: S0002-9149(04)01799-0
Knihovny.cz E-resources
- MeSH
- Adult MeSH
- Echocardiography MeSH
- Ethanol administration & dosage MeSH
- Cardiomyopathy, Hypertrophic diagnostic imaging therapy MeSH
- Ultrasonography, Interventional MeSH
- Middle Aged MeSH
- Humans MeSH
- Prospective Studies MeSH
- Chi-Square Distribution MeSH
- Aged MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Clinical Trial MeSH
- Randomized Controlled Trial MeSH
- Names of Substances
- Ethanol MeSH
This prospective, randomized study evaluates the association between ethanol dose and postprocedural hemodynamic changes in 42 patients treated by alcohol septal ablation for obstructive hypertrophic cardiomyopathy. These results suggest that the early course of hemodynamic changes is not related to the use of a small (1 to 2 ml) or standard (>2 ml) dose of ethanol.
References provided by Crossref.org
How to Treat Obstructions in Patients with Hypertrophic Cardiomyopathy
